• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

爱尔兰多发性硬化症患病率的纬度变化:遗传多样性的影响

Latitudinal variation in the prevalence of multiple sclerosis in Ireland, an effect of genetic diversity.

作者信息

McGuigan C, McCarthy A, Quigley C, Bannan L, Hawkins S A, Hutchinson M

机构信息

St Vincent's University Hospital, Elm Park, Dublin 4, Republic of Ireland.

出版信息

J Neurol Neurosurg Psychiatry. 2004 Apr;75(4):572-6. doi: 10.1136/jnnp.2003.012666.

DOI:10.1136/jnnp.2003.012666
PMID:15026499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1739004/
Abstract

BACKGROUND

Northern Ireland has a high and rising prevalence rate of multiple sclerosis (MS). The most recent survey in 1996 found a rate of 168.7/100 000. Recorded prevalence rates for the south of Ireland, including County Wexford, have been markedly lower and seemed to suggest the existence of a prevalence gradient within the island.

OBJECTIVES

To compare the prevalence of multiple sclerosis in Co. Wexford in the south east of Ireland and Co. Donegal in the north west, and to establish whether a variation in prevalence of MS exists within Ireland.

METHODS

Patients were referred from multiple sources. Review of clinical case records and/or patient examination confirmed the diagnosis.

RESULTS

In Co. Wexford, 126 patients were found to have clinically definite or probable multiple sclerosis with a prevalence rate of 120.7/100 000 (95% confidence intervals (CI) 100.6 to 143.8), which is similar to other areas of similar latitude within the British Isles. In Co. Donegal, 240 people had clinically definite or probable MS with a prevalence rate of 184.6/100 000 (95% CI 162.0 to 209.5). The difference in prevalence rates is statistically significant (Z = 3.94, p = <0.001).

CONCLUSION

There is a latitudinal variation in the prevalence rate of MS between the north and the south of Ireland. The increased prevalence of MS seen in Co. Wexford is likely to represent better case ascertainment and improved diagnostic accuracy rather than an actual increase in prevalence. The north/south variation in prevalence may represent a variation in the genetic predisposition to MS between the background populations of the two counties.

摘要

背景

北爱尔兰多发性硬化症(MS)的患病率较高且呈上升趋势。1996年的最新调查发现患病率为168.7/10万。爱尔兰南部,包括韦克斯福德郡,记录的患病率明显较低,似乎表明该岛存在患病率梯度。

目的

比较爱尔兰东南部韦克斯福德郡和西北部多尼戈尔郡多发性硬化症的患病率,并确定爱尔兰境内MS患病率是否存在差异。

方法

患者来自多个来源。通过回顾临床病例记录和/或对患者进行检查来确诊。

结果

在韦克斯福德郡,发现126例临床确诊或可能患有多发性硬化症的患者,患病率为120.7/10万(95%置信区间(CI)为100.6至143.8),这与不列颠群岛内其他纬度相似的地区相近。在多尼戈尔郡,240人临床确诊或可能患有MS,患病率为184.6/10万(95%CI为162.0至209.5)。患病率差异具有统计学意义(Z = 3.94,p = <0.001)。

结论

爱尔兰南北部MS患病率存在纬度差异。韦克斯福德郡MS患病率的增加可能代表病例确诊情况更好以及诊断准确性提高,而非实际患病率增加。患病率的南北差异可能代表两个郡背景人群中MS遗传易感性的差异。

相似文献

1
Latitudinal variation in the prevalence of multiple sclerosis in Ireland, an effect of genetic diversity.爱尔兰多发性硬化症患病率的纬度变化:遗传多样性的影响
J Neurol Neurosurg Psychiatry. 2004 Apr;75(4):572-6. doi: 10.1136/jnnp.2003.012666.
2
Population frequency of HLA haplotypes contributes to the prevalence difference of multiple sclerosis in Ireland.HLA单倍型的人群频率导致了爱尔兰多发性硬化症患病率的差异。
J Neurol. 2005 Oct;252(10):1245-8. doi: 10.1007/s00415-005-0850-8. Epub 2005 Sep 16.
3
Multiple sclerosis prevalence in Ireland: relationship to vitamin D status and HLA genotype.爱尔兰多发性硬化症的患病率:与维生素 D 状态和 HLA 基因型的关系。
J Neurol Neurosurg Psychiatry. 2011 Mar;82(3):317-22. doi: 10.1136/jnnp.2010.220988. Epub 2011 Jan 19.
4
Incidence of multiple sclerosis in the Republic of Ireland: A prospective population-based study.爱尔兰共和国多发性硬化症的发病率:一项前瞻性基于人群的研究。
Mult Scler Relat Disord. 2017 Apr;13:75-80. doi: 10.1016/j.msard.2017.02.010. Epub 2017 Feb 14.
5
Factors in the rising prevalence of multiple sclerosis in the north-east of Ireland.爱尔兰东北部多发性硬化症患病率上升的因素。
Mult Scler. 2008 Aug;14(7):880-6. doi: 10.1177/1352458508090663. Epub 2008 Jun 23.
6
An epidemiologic study of multiple sclerosis in Northern Ireland.北爱尔兰多发性硬化症的流行病学研究。
Neurology. 1998 Feb;50(2):423-8. doi: 10.1212/wnl.50.2.423.
7
Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis.纬度与多发性硬化症的患病率显著相关:一项荟萃分析。
J Neurol Neurosurg Psychiatry. 2011 Oct;82(10):1132-41. doi: 10.1136/jnnp.2011.240432. Epub 2011 Apr 8.
8
Multiple sclerosis in island populations: prevalence in the Bailiwicks of Guernsey and Jersey.岛屿人群中的多发性硬化症:根西岛和泽西岛辖区的患病率
J Neurol Neurosurg Psychiatry. 1995 Jan;58(1):22-6. doi: 10.1136/jnnp.58.1.22.
9
The prevalence of multiple sclerosis in the Leeds Health Authority.利兹卫生局辖区内多发性硬化症的患病率。
J Neurol Neurosurg Psychiatry. 1998 May;64(5):605-10. doi: 10.1136/jnnp.64.5.605.
10
Estimating the prevalence of multiple sclerosis in the United Kingdom by using capture-recapture methodology.运用捕获-再捕获法估算英国多发性硬化症的患病率。
Am J Epidemiol. 1999 Jun 1;149(11):1016-24. doi: 10.1093/oxfordjournals.aje.a009746.

引用本文的文献

1
Prevalence and incidence of multiple sclerosis in healthcare district IV of Asturias, Spain.西班牙阿斯图里亚斯第四医疗区多发性硬化症的患病率和发病率。
BMC Neurol. 2025 Mar 5;25(1):85. doi: 10.1186/s12883-025-04108-5.
2
Systematic literature review and meta-analysis of the prevalence of secondary progressive multiple sclerosis in the USA, Europe, Canada, Australia, and Brazil.系统文献回顾和荟萃分析美国、欧洲、加拿大、澳大利亚和巴西的继发进展性多发性硬化症的患病率。
BMC Neurol. 2022 Aug 17;22(1):301. doi: 10.1186/s12883-022-02820-0.
3
The Beneficial and Debilitating Effects of Environmental and Microbial Toxins, Drugs, Organic Solvents and Heavy Metals on the Onset and Progression of Multiple Sclerosis.环境和微生物毒素、药物、有机溶剂和重金属对多发性硬化症的发生和进展的有益和有害影响。
Toxins (Basel). 2019 Mar 5;11(3):147. doi: 10.3390/toxins11030147.
4
Management of optic neuritis in Ireland: a survey comparing the management practices of acute demyelinating optic neuritis amongst ophthalmologists and neurologists in Ireland.爱尔兰视神经炎的管理:一项比较爱尔兰眼科医生和神经科医生对急性脱髓鞘性视神经炎管理实践的调查。
Ir J Med Sci. 2019 Feb;188(1):277-282. doi: 10.1007/s11845-018-1817-y. Epub 2018 Apr 24.
5
The Irish DNA Atlas: Revealing Fine-Scale Population Structure and History within Ireland.爱尔兰 DNA 图谱:揭示爱尔兰内部的精细人口结构和历史。
Sci Rep. 2017 Dec 8;7(1):17199. doi: 10.1038/s41598-017-17124-4.
6
The incidence and prevalence of neuromyelitis optica: a systematic review.视神经脊髓炎的发病率和患病率:一项系统综述。
Int J MS Care. 2013 Fall;15(3):113-8. doi: 10.7224/1537-2073.2012-048.
7
Incidence and prevalence of multiple sclerosis in Europe: a systematic review.欧洲多发性硬化症的发病率和患病率:系统评价。
BMC Neurol. 2013 Sep 26;13:128. doi: 10.1186/1471-2377-13-128.
8
Geomagnetic disturbances may be environmental risk factor for multiple sclerosis: an ecological study of 111 locations in 24 countries.地磁扰动可能是多发性硬化症的环境风险因素:24 个国家 111 个地点的生态学研究。
BMC Neurol. 2012 Sep 24;12:100. doi: 10.1186/1471-2377-12-100.
9
A budget impact analysis of natalizumab use in Ireland.爱尔兰那他珠单抗使用的预算影响分析。
Ir J Med Sci. 2012 Jun;181(2):199-204. doi: 10.1007/s11845-011-0773-6. Epub 2011 Oct 20.
10
Disease-modifying drugs in multiple sclerosis: a review of expenditure in Ireland.多发性硬化症的疾病修正药物:爱尔兰支出的综述。
Ir J Med Sci. 2011 Jun;180(2):337-41. doi: 10.1007/s11845-011-0685-5. Epub 2011 Feb 4.

本文引用的文献

1
Prevalence of disseminated sclerosis in Northern Ireland.北爱尔兰播散性硬化症的患病率。
Ulster Med J. 1954 Mar;23(Suppl. 2):1-27.
2
The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis. A meta-analysis study.标准化发病率和患病率在多发性硬化症流行病学研究中的应用。一项荟萃分析研究。
Neuroepidemiology. 2003 Jan-Feb;22(1):65-74. doi: 10.1159/000067107.
3
The prevalence of multiple sclerosis in Tayside, Scotland: do latitudinal gradients really exist?苏格兰泰赛德地区多发性硬化症的患病率:纬度梯度真的存在吗?
J Neurol. 1999 Nov;246(11):1033-40. doi: 10.1007/s004150050509.
4
Development of a multiple sclerosis functional composite as a clinical trial outcome measure.开发一种多发性硬化功能综合指标作为临床试验结果测量指标。
Brain. 1999 May;122 ( Pt 5):871-82. doi: 10.1093/brain/122.5.871.
5
Estimating the prevalence of multiple sclerosis in the United Kingdom by using capture-recapture methodology.运用捕获-再捕获法估算英国多发性硬化症的患病率。
Am J Epidemiol. 1999 Jun 1;149(11):1016-24. doi: 10.1093/oxfordjournals.aje.a009746.
6
An epidemiologic study of multiple sclerosis in Northern Ireland.北爱尔兰多发性硬化症的流行病学研究。
Neurology. 1999 Jan 1;52(1):215-6. doi: 10.1212/wnl.52.1.214-a.
7
High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition.苏格兰东南部多发性硬化症的高发病率和患病率:遗传易感性证据。
J Neurol Neurosurg Psychiatry. 1998 Jun;64(6):730-5. doi: 10.1136/jnnp.64.6.730.
8
An epidemiologic study of multiple sclerosis in Northern Ireland.北爱尔兰多发性硬化症的流行病学研究。
Neurology. 1998 Feb;50(2):423-8. doi: 10.1212/wnl.50.2.423.
9
Multiple sclerosis in south Cambridgeshire: incidence and prevalence based on a district register.剑桥郡南部的多发性硬化症:基于地区登记册的发病率和患病率
J Epidemiol Community Health. 1996 Jun;50(3):274-9. doi: 10.1136/jech.50.3.274.
10
Prevalence of multiple sclerosis in Rochdale.罗奇代尔多发性硬化症的患病率。
J Neurol Neurosurg Psychiatry. 1996 Oct;61(4):415-7. doi: 10.1136/jnnp.61.4.415.